Publication: Extramedullary relapsed multiple myeloma treatment with 177Lu-labeled CXCR4 endoradiotherapy and dosimetric results
Loading...
Program
Organization Authors
Co-Authors
Uçar, Burcu
Wester, Hans-Jürgen
Date
Language
Type
Embargo Status
N/A
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
We created our first national clinical protocol of 177Lu-CXCR4 therapy for patient who have failed to respond to current therapy options. We also calculated the kidney, liver, and tumor dosimetry. The kidney's mean absorbed dose was calculated to be 0.45 Gy/GBq, the calculated radiation absorbed dose of the liver was 0.63 Gy/GBq, and the radiation absorbed doses of the tumors vary between 9.2 and 82 Gy/GBq. 177Lu-CXCR4 therapy produced a promising clinical response in our patient in acceptable radiation dose limits as a treatment option in heavily pretreated patients with advanced multiple myeloma.
Source
Publisher
Wolters Kluwer
Subject
Citation
item.page.haspartof
Source
Clinical Nuclear Medicine
item.page.ispartofseries
item.page.edition
DOI
10.1097/RLU.0000000000003705
item.page.datauri
item.page.link
Rights
N/A
Copyrights Note
Rights and licensing
N/A
